Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Rivanna Medical said it commercially launched its Accuro anesthesia guidance device in the U.S., and said it is in continuing discussions with 3 potential corporate partners.
The announcement was made at the American Society of Anesthesiologists annual meeting in San Diego last week. Read more
Allergan said it agreed to acquire Northwood Medical’s EarFold implant technology designed to correct prominent ears, with or without asymmetry, in patients 7 years or older.
The device from London-based Northwood is a small implantable strip of nitinol metal alloy that is inserted under the skin and grips ear cartilage, enhancing or creating the shape of the anti-helical fold and reducing ear prominence, the company said. Read more
Orthofix announced 3rd quarter earnings which topped expectations on Wall Street, as well as plans to repurchase $75 million in common stock, sending shares up in mid-day trading.
Orthofix reported losses of $1.4 million, or 4¢ per share, on sales of $101.2 million for the 3 months ended September 30. That amounts to a massive 403% slide on the bottom line, with sales growth of 0.2% compared to the same period last year. Read more